Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q2 FY22 results · Jul–Sep 2021
Advanced Enzyme Technologies reported revenue from operations of ₹127.08 crore (up 5.6% from Q2 FY21) and net profit of ₹30.27 crore (down 21.5% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 127.08 | 120.39 | +5.6% | 137.01 | −7.3% |
| Other income | 0.90 | 0.58 | +54.5% | 0.93 | −3.6% |
| Total income | 127.98 | 120.97 | +5.8% | 137.95 | −7.2% |
| Profit before tax | 41.24 | 51.91 | −20.5% | 54.93 | −24.9% |
| Net profit for the period | 30.27 | 38.56 | −21.5% | 39.86 | −24.1% |
| EPS, basic (₹) | 2.66 | 3.33 | −20.1% | 3.40 | −21.8% |
| Net margin (%) | 23.8 | 32.0 | 29.1 |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 64.91 | 72.31 | −10.2% | 72.75 | −10.8% |
| Other income | 1.90 | 1.74 | +9.6% | 0.94 | +101.7% |
| Total income | 66.81 | 74.05 | −9.8% | 73.69 | −9.3% |
| Profit before tax | 17.25 | 28.21 | −38.9% | 25.09 | −31.3% |
| Net profit for the period | 12.84 | 20.13 | −36.2% | 18.55 | −30.8% |
| EPS, basic (₹) | 1.15 | 1.80 | not comparable | 1.66 | not comparable |
| Net margin (%) | 19.8 | 27.8 | 25.5 |
Consolidated
- Filed with BSE
- 02 Nov 2021, 19:18 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Nov 2021, 19:18 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE